Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin (2024 - 2025)

Incannex Healthcare (IXHL) has disclosed EBITDA Margin for 2 consecutive years, with 136160.0% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 8359333.0% to 136160.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 483030.0% through Dec 2025, down 45468698.0% year-over-year, with the annual reading at 54302.33% for FY2025, 10016434.0% up from the prior year.
  • EBITDA Margin hit 136160.0% in Q4 2025 for Incannex Healthcare, down from 123680.0% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 6866.22% in Q3 2024 to a low of 136160.0% in Q4 2025.